Smartleaf Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.5K Sell
2,141
-4,228
-66% -$88K ﹤0.01% 1519
2025
Q4
$139K Buy
6,369
+119
+2% +$2.44K 0.01% 1005
2025
Q3
$101K Buy
6,250
+601
+11% +$9.01K 0.01% 1064
2025
Q2
$79.3K Sell
5,649
-569
-9% -$7.8K 0.01% 957
2025
Q1
$88K Sell
6,218
-683
-10% -$9.7K 0.01% 882
2024
Q4
$91.2K Buy
6,901
+6,090
+751% +$84.1K 0.01% 878
2024
Q3
$9.13K Sell
811
-623
-43% -$5.87K ﹤0.01% 1806
2024
Q2
$10.4K Buy
+1,434
New +$11.9K ﹤0.01% 1388

Other funds holding MD

Smartleaf Asset Management's MD Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Pediatrix Medical (MD) stake by 66% in Q1 2026, selling an estimated $88K and leaving 2,141 shares worth $44.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

Smartleaf Asset Management first reported a position in MD in Q2 2024 and has held it in 8 quarters since. The position peaked at $139K in Q4 2025. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Smartleaf Asset Management held 2,141 shares of Pediatrix Medical worth $44.5K as of Q1 2026.
  • Smartleaf Asset Management sold 4,228 Pediatrix Medical shares in Q1 2026, an estimated $88K.
  • Pediatrix Medical made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #1519 holding.
  • Smartleaf Asset Management first reported a position in Pediatrix Medical in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Pediatrix Medical position peaked at $139K in Q4 2025.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.